Celestica Inc offers supply chain solutions... Show more
Celestica Inc. stands as a leader in electronics manufacturing services (EMS), specializing in high-complexity design, manufacturing, and supply chain solutions for innovative companies. Its competitive edge lies in the CCS segment, which now comprises over 65% of revenue and focuses on hyperscale data centers, networking, and AI-related compute infrastructure. The company benefits from deep engineering expertise, preferred supplier status with major hyperscalers, and early leadership in advanced technologies like 800G and 1.6T Ethernet switches. This positions Celestica favorably amid industry consolidation, where scale in high-reliability production differentiates it from broader EMS peers. Medium-term, ongoing capacity expansions and new program wins enhance market share in the fast-growing AI supply chain, though competition from larger players like Flex remains a structural challenge.
The Q1 2026 earnings release on April 27, 2026, after market close, followed by a conference call on April 28, represents a pivotal near-term event. Investors will scrutinize updates on CCS momentum and Q1 revenue guidance of $3.85-4.15 billion. Additional catalysts include ramping production for hyperscaler 1.6T programs starting in 2027 and U.S. manufacturing expansions for Google's Tensor Processing Unit (TPU) systems, set for completion in 2027. Recent analyst actions signal optimism, with multiple upgrades in April 2026, including Bank of America raising its target to $430 and JPMorgan to $410, reflecting improved demand visibility. Consensus earnings growth for 2026 is projected at 48.75% to $9.00 EPS, underscoring potential for positive revisions if AI demand sustains.
Celestica's trajectory is closely tied to the AI infrastructure supercycle, driven by hyperscalers' massive capital expenditures on data centers and networking gear. Surging demand for AI compute and high-speed connectivity provides strong tailwinds, with CCS revenue up 64% in Q4 2025. Macro sensitivities include interest rates, where lower levels could accelerate capex, and geopolitical tensions affecting supply chains or tariffs—though management assumes recovery of tariff costs from customers. Inflation in commodities like semiconductors poses margin risks, but Celestica's diversified global footprint and customer-funded expansions mitigate these. Broader technology adoption trends, such as edge AI and cloud migration, further bolster the EMS sector's evolution.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality for timely insights. Traders can leverage this engine to enhance decision-making in dynamic markets.
For 2026, Celestica has raised its revenue guidance to $17.0 billion and adjusted EPS to $8.75, driven by sustained AI-related demand and CCS growth. Key structural drivers include market expansion via hyperscaler partnerships, cost efficiencies from scaled production, and margin sustainability through higher-value HPS (Hardware Platform Solutions). Technology transitions to next-gen networking and U.S.-based capacity will support revenue trajectory into 2027. Competitive threats from capacity gluts or rival EMS providers warrant monitoring, alongside regulatory shifts in trade and data sovereignty. Consensus analyst expectations, with 2027 EPS forecasted at $12.99, reflect optimism around long-term AI infrastructure buildout and Celestica's entrenched positioning. Capital allocation prioritizes organic growth funding via strong cash flows.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a provider of electronics manufacturing services
Industry ElectronicComponents
A.I.dvisor indicates that over the last year, CLS has been closely correlated with FN. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLS jumps, then FN could also see price increases.
| Ticker / NAME | Correlation To CLS | 1D Price Change % | ||
|---|---|---|---|---|
| CLS | 100% | +6.28% | ||
| FN - CLS | 66% Closely correlated | +6.41% | ||
| TTMI - CLS | 65% Loosely correlated | N/A | ||
| GLW - CLS | 58% Loosely correlated | -0.10% | ||
| FLEX - CLS | 53% Loosely correlated | N/A | ||
| BHE - CLS | 51% Loosely correlated | +3.87% | ||
More | ||||
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CLS advanced for three days, in of 370 cases, the price rose further within the following month. The odds of a continued upward trend are .
CLS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 10-day RSI Indicator for CLS moved out of overbought territory on June 04, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 59 similar instances where the indicator moved out of overbought territory. In of the 59 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on June 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CLS as a result. In of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CLS turned negative on June 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .
CLS moved below its 50-day moving average on June 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CLS crossed bearishly below the 50-day moving average on June 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CLS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CLS's P/B Ratio (20.661) is slightly higher than the industry average of (7.839). P/E Ratio (45.678) is within average values for comparable stocks, (94.423). CLS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.454). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (3.168) is also within normal values, averaging (6.330).